1. Home
  2. List
Reference Patent

Reference - List

  • 78 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / metabolism*)
Species Resource Title
Human and Animal Cells Hep G2 Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner.
Human and Animal Cells Hep G2(RCB0459) Stimulation of apolipoprotein E secretion in human hepatoma Hep G2 cells by a cyclic acylpeptide, N-4909.
Human and Animal Cells HuH-7 Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.
Human and Animal Cells Hep G2(RCB1886) Dual-color fluorescence imaging to monitor CYP3A4 and CYP3A7 expression in human hepatic carcinoma HepG2 and HepaRG cells.
Human and Animal Cells HuH-6(RCB1367) , Hep G2 , HuH-7(RCB1366) SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells.
Human and Animal Cells HuH-7(RCB1366) The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblasts.
Human and Animal Cells HuH-7(RCB1366) Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
Human and Animal Cells HuH-7 First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.
Human and Animal Cells Hep G2(RCB1648) , HuH-7(RCB1366) The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
Human and Animal Cells HuH-7(RCB1366) Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Human and Animal Cells Hep G2 (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
Human and Animal Cells HuH-7(RCB1366) , Hep G2(RCB1886) CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma.
Human and Animal Cells HuH-7 TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.
Human and Animal Cells Hep G2 Bortezomib-resistance is associated with increased levels of proteasome subunits and apoptosis-avoidance.
Human and Animal Cells Hep G2(RCB1648) Development of biparatopic bispecific antibody possessing tetravalent scFv-Fc capable of binding to ROBO1 expressed in hepatocellular carcinoma cells.
Human and Animal Cells HuH-7 Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Human and Animal Cells Hep G2(RCB1886) Comparative analysis of bilirubin glucuronidation activity in 2D- and 3D-cultured human hepatocellular carcinoma HepG2 cells.
Human and Animal Cells HuH-7 Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest.
Human and Animal Cells Li-7(RCB1941) A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7.
Human and Animal Cells HuH-7 , Hep G2(RCB1886) Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway.